ExCEEd Orphan continues cooperation with AveXis for Zolgensma® June 1, 2020 AveXis continues in cooperation with ExCEEd Orphan in North Macedonia for Zolgensma®, the only approved gene therapy for spinal muscular atrophy (SMA)
